| Literature DB >> 35456134 |
Lorena Biasini1, Paola Berto1, Miriam Abbadi1, Alessandra Buratin1, Marica Toson1, Andrea Marsella1, Anna Toffan1, Francesco Pascoli1.
Abstract
European sea bass (Dicentrarchus labrax) is an important farmed marine species for Mediterranean aquaculture. Outbreaks of betanodavirus represent one of the main infectious threats for this species. The red-spotted grouper nervous necrosis virus genotype (RGNNV) is the most widely spread in Southern Europe, while the striped jack nervous necrosis virus genotype (SJNNV) has been rarely detected. The existence of natural reassortants between these genotypes has been demonstrated, the RGNNV/SJNNV strain being the most common. This study aimed to evaluate the pathogenicity of different RGNNV/SJNNV strains in European sea bass. A selection of nine European reassortants together with parental RGNNV and SJNNV strains were used to perform in vivo experimental challenges via intramuscular injection. Additional in vivo experimental challenges were performed by bath immersion in order to mimic the natural infection route of the virus. Overall, results on survival rates confirmed the susceptibility of European sea bass to reassortants and showed different levels of induced mortalities. Results obtained by RT-qPCR also highlighted high viral loads in asymptomatic survivors, suggesting a possible reservoir role of this species. Our findings on the comparison of complete genomic segments of all reassortants have shed light on different amino acid residues likely involved in the variable pathogenicity of RGNNV/SJNNV strains in European sea bass.Entities:
Keywords: European sea bass; betanodavirus; pathogenicity; reassortant; viral encephalopathy and retinopathy
Year: 2022 PMID: 35456134 PMCID: PMC9026442 DOI: 10.3390/pathogens11040458
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Data on fish betanodavirus isolates used in this study for experimental challenges.
| Strain | Abbreviation | Year | Host | Origin | Genotype | RNA1 | RNA2 | Reference |
|---|---|---|---|---|---|---|---|---|
| GenBank Accession No. | ||||||||
| 283.2009 | 283 | 2009 |
| Italy | RG | JN189865.2 | JN189992.2 | [ |
| 132.2005 | 132 | 2005 |
| Italy | RG/SJ | JN189899.2 | JN189937.2 | [ |
| 292.7.8.2009 | 292-7.8 | 2009 |
| Greece | RG/SJ | JN189833.2 | JN189924.2 | [ |
| 292.1.2.2009 | 292-1.2 | 2009 |
| Greece | RG/SJ | JN189831.2 | JN189922.2 | [ |
| VNNV/D.labrax/I/187/Mar2018 | 187 | 2018 |
| Italy | RG/SJ | OL955903 | OL955907 | This study |
| 367.2.2005 | 367-2 | 2005 |
| Italy | RG/SJ | JN189909.2 | JN189936.2 | [ |
| VNNV/D.labrax/ES/61-48/Feb2016 | 61-48 | 2016 |
| Spain | RG/SJ | OL955902 | OL955906 | This study |
| VNNV/S.aurata/I/188/Mar2018 | 188 | 2018 |
| Italy | RG/SJ | OL955904 | OL955908 | This study |
| VNNV/S.aurata/Farm1/461-1/Nov2014 | 461-1 | 2014 |
|
| RG/SJ | KY354688.2 | KY354702.2 | [ |
| VNNV/S.aurata/Farm2/165-6/Mar2016 | 165-6 | 2016 |
|
| RG/SJ | KY354693.2 | KY354706.2 | [ |
| VNNV/S.solea/ES/540-7/Dec2009 | 540-7 | 2009 |
| Spain | SJ | OL955905 | OL955909 | This study |
| 484.2.2009 | 484-2 | 2009 |
| Spain | SJ | JN189814.2 | JN189919.2 | [ |
n.d. = not disclosed.
Results obtained in both intramuscular injection and bath immersion challenges.
| Route of Viral Infection | Challenge Group | TCID50/mL 1 | % Mortality (95% CI) | LCN ± SD 2 |
|---|---|---|---|---|
|
| RG283 | 105.80 | 34.55 (22.24–48.58) | 5.26 ± 0.16 |
| RG/SJ132 | 106.80 | 26.00 (14.63–40.35) | 4.81 ± 0.32 | |
| RG/SJ292-7.8 | 105.80 | 15.69 (7.02–28.59) |
| |
| RG/SJ292-1.2 | 105.80 | 12.73 (5.27–24.48) | 4.84 ± 0.48 | |
| RG/SJ187 | 106.05 | 10.91 (4.11–22.25) | 4.90 ± 0.27 | |
| RG/SJ367-2 | 105.80 | 7.14 (1.98–17.29) | 5.01 ± 0.47 | |
| RG/SJ61-48 | 107.05 | 6.38 (1.34–17.54) | 4.82 ± 0.21 | |
| RG/SJ188 | 106.80 | 5.66 (1.18–15.66) |
| |
| RG/SJ461-1 | 107.55 | 4.08 (0.50–13.98) | 4.34 ± 0.31 | |
| RG/SJ165-6 | 106.55 | 2.04 (0.05–10.85) | 4.74 ± 0.27 | |
| SJ540-7 | 106.80 | 1.82 (0.05–9.72) |
| |
| SJ484-2 | 107.30 | 0.00 (0.00–6.49) |
| |
|
| RG283 | 105.05 | 18.52 (9.25–31.43) | 4.67 ± 0.39 |
| RG/SJ132 | 105.05 | 7.41 (2.06–17.89) | 4.79 ± 0.37 | |
| RG/SJ292-7.8 | 105.05 | 3.70 (0.45–12.75) | 4.27 ± 0.58 | |
| RG/SJ461-1 | 105.05 | 7.41 (2.06–17.89) | 4.43 ± 1.08 # |
1 TCID50 refers to the mL of inoculum injected in the intramuscular challenge or to the mL of infected water used in the bath immersion challenge; 2 LCN is reported as mean logarithmic value of RNA1 gene copy number detected in 20 ng of total RNA of analyzed survivor fish (n = 5) and relative standard deviation (SD); # calculated on 3 fish with values > LoQ; n.a. = not analyzed (not suitable primers for strain detection); n.e. = not executed (nucleotides identity between strains 187 and 188 and between 292-1.2 and 292-7.8 ≥ 99.9%).
Figure 1Kaplan–Meier survival curves of the 12 isolates tested for their virulence in ESB. (A) Trial by intramuscular injection; (B) trial by bath immersion. The y-axis reports the survival rate; the x-axis reports the observation period expressed as days post infection (dpi). Step curves represent the survival rate of challenged fish in each experimental group.
Figure 2RT-qPCR results in survivors. (A) Trial by intramuscular injection; (B) trial by bath immersion. The x-axis reports the different challenged groups. The y-axis reports viral RNA1 gene copy numbers detected in brains. Values are expressed as Log10 of copy numbers (LCN) detected in 20 ng of total RNA. For each subject, LCN values are depicted as circles, while the horizontal lines indicate the mean LCN value. Only LCN ≥ LoQ are considered. * = p-value < 0.05.
Figure 3ML phylogenetic trees of (A) RNA1 complete ORF and (B) RNA2 complete ORF. Isolates used for experimental infections are in bold and compared to betanodavirus representative sequences retrieved from GenBank. The numbers at branch points correspond to bootstrap values expressed as percentages (only values ≥70 are reported). The genotype subdivision according to Nishizawa et al. [10] is shown at the main branches. Scale bars represent nucleotide substitutions per site.
Figure 4Modeling of reference SJ strain (540-7) capsid protein. In the ribbon, representations of the monomer different colors are reported, indicating the variable amino acids in the P-domain region. Residues color codes are blue for 292, 293 and 298; red for 223, 291 and 297; yellow for 299.